Jőrg‐Peter Kleim

Single-Dose Tafenoquine to Prevent Relapse of <i>Plasmodium vivax</i> Malaria

Marcus Lacerda, Alejandro Llanos‐Cuentas, Srivicha Krudsood et al. · New England Journal of Medicine · 2019 · 277 citations · Full text

Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study

Alejandro Llanos‐Cuentas, Marcus Lacerda, Ronnatrai Rueangweerayut et al. · The Lancet · 2013 · 242 citations

Antiparasitic Agent, Medicine, Malaria +6

The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance

Y. Hsiou, Jianping Ding, Kalyan Das et al. · Journal of Molecular Biology · 2001 · 194 citations

Lys103asn Mutation, Human Retrovirus, Hiv-1 Rt +10

Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro

Michael Maguire, Rosario Guinea, Philip Griffin et al. · Journal of Virology · 2002 · 157 citations · Full text

Viral Replication, Immunology, I50v Protease Mutants +18

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers

Ronnatrai Rueangweerayut, Germana Bancone, Emma J. Harrell et al. · American Journal of Tropical Medicine and Hygiene · 2017 · 117 citations · Full text